187 related articles for article (PubMed ID: 18064859)
1. [Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
Ypenburg C; Verwey HF; van der Wall EE
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2426-8. PubMed ID: 18064859
[TBL] [Abstract][Full Text] [Related]
2. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
[TBL] [Abstract][Full Text] [Related]
3. Home inotropic therapy in children.
Berg AM; Snell L; Mahle WT
J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
[TBL] [Abstract][Full Text] [Related]
4. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
Upadya S; Lee FA; Saldarriaga C; Verma S; Sedrakyan A; Nystrom K; Katz SD
J Heart Lung Transplant; 2004 Apr; 23(4):466-72. PubMed ID: 15063407
[TBL] [Abstract][Full Text] [Related]
5. Infusion therapy with milrinone in the home care setting for patients who have advanced heart failure.
Boger JE; DeLuca SL; Watkins DF; Vershave KK; Thomley AM
J Intraven Nurs; 1997; 20(3):148-54. PubMed ID: 9214927
[TBL] [Abstract][Full Text] [Related]
6. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
7. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
8. Home intravenous dobutamine therapy in patients awaiting heart transplantation.
Collins JA; Skidmore MA; Melvin DB; Engel PJ
J Heart Transplant; 1990; 9(3 Pt 1):205-8. PubMed ID: 2355273
[TBL] [Abstract][Full Text] [Related]
9. Dobutamine infusion for the treatment of congestive heart failure in the home care setting.
Coffin MR
J Intraven Nurs; 1994; 17(3):145-50. PubMed ID: 8064499
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
Brozena SC; Twomey C; Goldberg LR; Desai SS; Drachman B; Kao A; Popjes E; Zimmer R; Jessup M
J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175
[TBL] [Abstract][Full Text] [Related]
11. Outpatient dobutamine for end-stage congestive heart failure.
Miller LW; Merkle EJ; Herrmann V
Crit Care Med; 1990 Jan; 18(1 Pt 2):S30-3. PubMed ID: 2293976
[TBL] [Abstract][Full Text] [Related]
12. Inotropic therapy for heart failure: an evidence-based approach.
Felker GM; O'Connor CM
Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
[TBL] [Abstract][Full Text] [Related]
13. Inotropic therapy in the home care setting: criteria, management, and implications.
Mayes J; Carter C; Adams JE
J Intraven Nurs; 1995; 18(6):301-6. PubMed ID: 8699289
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
Bayram M; De Luca L; Massie MB; Gheorghiade M
Am J Cardiol; 2005 Sep; 96(6A):47G-58G. PubMed ID: 16181823
[TBL] [Abstract][Full Text] [Related]
15. The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.
de Lissovoy G; Fraeman K; Salon J; Chay Woodward T; Sterz R
J Med Econ; 2008; 11(3):415-29. PubMed ID: 19450096
[TBL] [Abstract][Full Text] [Related]
16. Outpatient use of dobutamine to support patients awaiting heart transplantation.
Miller LW; Merkle EJ; Jennison SH
J Heart Lung Transplant; 1994; 13(4):S126-9. PubMed ID: 7947869
[No Abstract] [Full Text] [Related]
17. Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.
Nanas S; Gerovasili V; Dimopoulos S; Pierrakos C; Kourtidou S; Kaldara E; Sarafoglou S; Venetsanakos J; Roussos C; Nanas J; Anastasiou-Nana M
J Card Fail; 2008 Jun; 14(5):400-6. PubMed ID: 18514932
[TBL] [Abstract][Full Text] [Related]
18. [Terminal heart failure; therapeutic strategies. Drug therapy in cases of absence of possibility of heart transplantation: dobutamine therapy, aspects of compassion?].
Roul G; Bareiss P
Arch Mal Coeur Vaiss; 1996 Nov; 89 Spec No 6():27-32. PubMed ID: 9092423
[TBL] [Abstract][Full Text] [Related]
19. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
[TBL] [Abstract][Full Text] [Related]
20. Long-term (> 8 weeks) home inotropic therapy as destination therapy in patients with advanced heart failure or as bridge to heart transplantation.
Jiménez J; Jara J; Bednar B; Bauerlein J; Mallon S
Int J Cardiol; 2005 Mar; 99(1):47-50. PubMed ID: 15721498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
